2023 PharmaPoint: Global Asthma Drug Market Growth
Big Market Research, PharmaPoint: Global Asthma Drug Market Size, Share, Strategies, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities. More info @ http://www.bigmarketresearch.com/pharmapoint-asthma-global-drug-forecast-and-analysis-to-2023-market Big Market Research added a new research report "PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023". Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade. The largest unmet needs mainly reflect the high level of heterogeneity of the disease, the lack of patient compliance with the standard therapies, and the high cost of medications for asthma treatment. In addition, there is a lack of diagnostic tools to provide a reliable diagnosis of asthma in young children. Annualized asthma therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.
Big Market Research, PharmaPoint: Global Asthma Drug Market Size, Share, Strategies, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities. More info @ http://www.bigmarketresearch.com/pharmapoint-asthma-global-drug-forecast-and-analysis-to-2023-market
Big Market Research added a new research report "PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023". Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade. The largest unmet needs mainly reflect the high level of heterogeneity of the disease, the lack of patient compliance with the standard therapies, and the high cost of medications for asthma treatment. In addition, there is a lack of diagnostic tools to provide a reliable diagnosis of asthma in young children. Annualized asthma therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Report Description<br />
Big <strong>Market</strong> Research added a new research report "<strong>PharmaPoint</strong>: <strong>Asthma</strong> - <strong>Global</strong> <strong>Drug</strong><br />
Forecast and <strong>Market</strong> Analysis to <strong>2023</strong>". <strong>Asthma</strong> accounts for approximately 250,000<br />
deaths around the world annually, deaths that otherwise could be easily prevented<br />
through appropriate treatment The asthma market saw very slow growth over the past<br />
decade, as it has become saturated with relatively efficacious standard therapies, such as<br />
short-acting beta-agonists (SABAs), inhaled corticosteroids (ICSs), inhaled corticosteroids<br />
and long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and has also been<br />
facing increasing generic competition. However, the launch of seven novel targeted<br />
biologic agents and once-daily ICS and ICS/LABA therapies delivered by the nextgeneration<br />
inhalers will strongly drive the market growth over the next 10 years. The<br />
biologic agents will not only reshape the market growth, but will also mark the beginning<br />
of a new era of a personalized approach to asthma treatment.<br />
To request more information Visit @<br />
http://www.bigmarketresearch.com/pharmapoint-asthma-global-drug-forecast-andanalysis-to-<strong>2023</strong>-market
Change language